Scleroderma Specific Autoantibodies in Rheumatoid Arthritis and Sjögren's Syndrome Patients with Interstitial Lung Disease: Prevalence and Associations

Overview

Journal J Transl Autoimmun

Date 2023 Jan 9

PMID 36619654

Authors

Vasiliki Koulouri

Athanasios-Dimitrios Bakasis

Nikolaos Marketos

Kyriaki Tavernaraki

Mayra Giannelou

Haralampos M Moutsopoulos

Clio P Mavragani

Affiliations

Soon will be listed here.

Abstract

Systemic sclerosis (SSc) has been classically linked to interstitial lung disease (ILD) development, often in association with specific SSc autoantibodies. In the present report, we aimed to estimate the prevalence of SSc autoantibodies in 60 seropositive RA and 41 primary SS patients complicated or not by ILD. SSc autoantibodies were determined in patients' sera by a commercial immunoblot assay. RA ILD patients displayed higher frequency of SSc-specific antibodies at strong titers compared to RA-with no lung involvement (25% vs 3.1%, p = 0.01)[OR 95% CI:10.9 (1.2-94.5)], with no differences detected between primary SS groups. These data indicate that many seropositive RA ILD patients probably represent an overlap RA/SSc entity, requiring tailored diagnostic and therapeutic approach.

References

Lin W, Xin Z, Zhang J, Liu N, Ren X, Liu M . Interstitial lung disease in Primary Sjögren's syndrome. BMC Pulm Med. 2022; 22(1):73. PMC: 8882286. DOI: 10.1186/s12890-022-01868-5. View

Spagnolo P, Lee J, Sverzellati N, Rossi G, Cottin V . The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease. Arthritis Rheumatol. 2018; 70(10):1544-1554. DOI: 10.1002/art.40574. View

Kuwana M, Gil-Vila A, Selva-OCallaghan A . Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis. 2021; 13:1759720X211032457. PMC: 8320553. DOI: 10.1177/1759720X211032457. View

Didier K, Bolko L, Giusti D, Toquet S, Robbins A, Antonicelli F . Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?. Front Immunol. 2018; 9:541. PMC: 5879136. DOI: 10.3389/fimmu.2018.00541. View

Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham 3rd C . 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010; 69(9):1580-8. DOI: 10.1136/ard.2010.138461. View

Skopouli F, Andonopoulos A, Moutsopoulos H . Clinical implications of the presence of anti-Ro (SSA) antibodies in patients with rheumatoid arthritis. J Autoimmun. 1988; 1(4):381-8. DOI: 10.1016/0896-8411(88)90008-x. View

Seror R, Ravaud P, Bowman S, Baron G, Tzioufas A, Theander E . EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis. 2009; 69(6):1103-9. PMC: 2937022. DOI: 10.1136/ard.2009.110619. View

Kronzer V, Huang W, Dellaripa P, Huang S, Feathers V, Lu B . Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease. J Rheumatol. 2020; 48(5):656-663. PMC: 8096643. DOI: 10.3899/jrheum.200863. View

Jee A, Adelstein S, Bleasel J, Keir G, Nguyen M, Sahhar J . Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). J Clin Med. 2017; 6(5). PMC: 5447942. DOI: 10.3390/jcm6050051. View

10.

Moutsopoulos H, Skopouli F, Sarras A, Tsampoulas C, Mavridis A, Constantopoulos S . Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. Ann Rheum Dis. 1985; 44(4):215-9. PMC: 1001615. DOI: 10.1136/ard.44.4.215. View

11.

Lee A, Scofield R, Hammitt K, Gupta N, Thomas D, Moua T . Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's. Chest. 2020; 159(2):683-698. PMC: 8438162. DOI: 10.1016/j.chest.2020.10.011. View

12.

Hamaguchi Y, Kuwana M, Takehara K . Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies. Clin Rheumatol. 2020; 39(11):3489-3497. DOI: 10.1007/s10067-020-04973-0. View

13.

Palucka A, Blanck J, Bennett L, Pascual V, Banchereau J . Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci U S A. 2005; 102(9):3372-7. PMC: 552921. DOI: 10.1073/pnas.0408506102. View

14.

Bournia V, Diamanti K, Vlachoyiannopoulos P, Moutsopoulos H . Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis. Arthritis Res Ther. 2010; 12(2):R47. PMC: 2888196. DOI: 10.1186/ar2958. View

15.

Marketos N, Koulouri V, Piperi E, Georgaki M, Nikitakis N, Mavragani C . Scleroderma-specific autoantibodies: Should they be included in the diagnostic work-up for Sjögren's syndrome?. Semin Arthritis Rheum. 2022; 55:152026. DOI: 10.1016/j.semarthrit.2022.152026. View

16.

Ivashkiv L . Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis. Autoimmunity. 2004; 36(8):473-9. DOI: 10.1080/08916930310001605882. View

17.

Ruaro B, Confalonieri M, Matucci-Cerinic M, Salton F, Confalonieri P, Santagiuliana M . The Treatment of Lung Involvement in Systemic Sclerosis. Pharmaceuticals (Basel). 2021; 14(2). PMC: 7918752. DOI: 10.3390/ph14020154. View

18.

Huang Y, Lin W, Chen Z, Wang Y, Huang Y, Tu S . Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?. Drug Des Devel Ther. 2019; 13:2111-2125. PMC: 6616146. DOI: 10.2147/DDDT.S204730. View

19.

Horimoto A, da Costa I . Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?. Rev Bras Reumatol Engl Ed. 2016; 56(4):287-98. DOI: 10.1016/j.rbre.2014.12.011. View

20.

Montero P, Milara J, Roger I, Cortijo J . Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms. Int J Mol Sci. 2021; 22(12). PMC: 8226626. DOI: 10.3390/ijms22126211. View